Guardant Health
GH
#1121
Rank
HK$154.65 B
Marketcap
HK$1,143
Share price
0.16%
Change (1 day)
39.34%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report